-- Continued progress in the PIKture-01 trial; on track to report additional data in the second half of 2025, including mature single agent and initial combination data
Read more at globenewswire.com
OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
Provided By GlobeNewswire - Last update: May 6, 2025
Article Mentions:
NASDAQ:OKUR (2/26/2026, 4:30:02 PM)
2.66
-0.05 (-1.85%)
Find more stocks in the Stock Screener
